Guest guest Posted October 20, 2011 Report Share Posted October 20, 2011 News 10 new results for hepatitis c Vertex CEO sees "historic launch" for Hep-C drugReutersBy Ros Krasny BOSTON, Oct 20 (Reuters) - The chief executive of Vertex Pharmaceuticals Inc , Emmens, said on Thursday that adoption of its recently-launched hepatitis C drug, Incivek, has been "very very fast." The first full quarter of US ...See all stories on this topic » Interim Phase IIb Data for Merck's VICTRELIS (boceprevir) in Patients ...MarketWatch (press release)The interim analysis showed that at week 24 of treatment, 70.5 percent (n=43/61) of patients receiving VICTRELIS in combination with peginterferon alfa-2b and ribavirin had undetectable hepatitis C virus (HCV-RNA) compared to 34.4 percent (n=11/32) of ...See all stories on this topic » Widow of firefighter with hepatitis C due death benefits: Pa. high courtBusiness InsurancePHILADELPHIA—A doctor's testimony was insufficient to refute a Pennsylvania law's presumption that a firefighter contracted hepatitis C on the job, the Pennsylvania Supreme Court has ruled. In a unanimous decision Wednesday, the high court said ...See all stories on this topic » U.S. Hepatitis C MarketSYS-CON Media (press release)NEW YORK, Oct. 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: This research service covers the US hepatitis C (HCV) market from 2008 to 2016, with 2010 as the base year. ...See all stories on this topic » US Hepatitis C MarketMarketWatch (press release)NEW YORK, Oct. 20, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue:See all stories on this topic » Pa. high court sides with widow in hepatitis case | Philadelphia Inquirer ...Philadelphia InquirerThe Pennsylvania Supreme Court on Wednesday found in favor of the widow of a Philadelphia firefighter who claimed he got hepatitis C from his job. Kriebel filed a workers' compensation claim after her husband, ph Kriebel, 52, ...See all stories on this topic » Roche to Acquire Anadys Pharmaceuticals for $230MSan Diego Business JournalJust days after releasing promising data from its midstage clinical trial for a drug that treats the hepatitis C virus, San Diego-based Anadys Pharmaceuticals Inc. said it would be acquired by Swiss drugmaker Roche Holding AG for $230 million — a 256 ...See all stories on this topic » Clinic patients couldn't properly consent to procedureOttawa CitizenThis meant that there was a risk of these patients contracting a nasty disease such as hepatitis B, hepatitis C, or HIV. Did Ottawa Public Health do the right thing in informing these patients? There is actually a case against informing the patients. ...See all stories on this topic » American Association for the Study of Liver Diseases President's Press ...MarketWatch (press release)08 - 10:45 AM Room: 2011 The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the CC IL-28B Polymorphism Ziad Gellad, et al. Monday, Nov. 07 - 8:00 AM Room 3000-3012 A ....See all stories on this topic » Vertex applies for 2nd FDA approval in '11: First treatment for cystic fibrosisExaminer.comWe reviewed Vertex's efforts to get Incivek, the drug for hepatitis C, approved in May 2011 in the article Phase III results from Vertex: 75% of Hepatitis C patients cured after treatment with telaprevir Now Vertex has announced it has filed for ...See all stories on this topic » - more news http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.